Jessica Ansari
Pacifica, California, 94044, United States
NCT Number: NCT05027048
Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality worldwide. Up to 80% of PPH is caused by uterine atony, the failure of the uterine smooth muscle to contract and compress the uterine vasculature after delivery. Laboratory and epidemiological studies show that low extracellular and serum calcium levels, respectively, decrease uterine contractility. A pilot study performed by the investigators supports the hypothesis that intravenous calcium chloride is well tolerated and may have utility in preventing uterine atony. The proposed research will establish the relationship between uterine tone and calcium through a clinical trial with an incorporated pharmacokinetic and pharmacodynamic (PK/PD) study. In a randomized, placebo-controlled, double-blind trial, investigators will establish the effect of 1 gram of intravenous calcium chloride upon quantitative blood loss and uterine tone during cesarean delivery in parturients with high risk of uterine atony. Investigators will concurrently collect serial venous blood samples to measure calcium for PK/PD modeling in this pregnant study cohort. High-quality clinical research and development of novel therapeutics to manage uterine atony are critical to reduce the high maternal morbidity and mortality from PPH.
Looking for future studies?
Notify Me18 year–55 year
Female
Interventional
Phase 3
Pacifica, California, 94044, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
See arm description above
see arm description above
Time frame: measurement occurs at conclusion of operating room case
Standardized volumetric and gravimetric assessment of blood loss during cesarean. Note: will analyze all participants, but planned subgroup analysis will also occur excluding patients with non-atonic reasons for blood loss including hysterotomy extension, placental abruption, cervical or vaginal laceration, etc
Time frame: operative course (within 4-6 hours of fetal delivery)
Postpartum hemorrhage was defined as quantitative blood loss > 1000 milliliters during operative course
Time frame: within 4 hours of delivery
Yes/no: did the patient require treatment with methylergonovine, carboprost, and/or misoprostol for uterine atony
Time frame: 96 hours of delivery
Yes/no, if patient required transfusion of packed red blood cells prior to hospital discharge
Time frame: 1 day
Measured pre-delivery hematocrit minus measured post-operative day 1 hematocrit. Correction factor of 3 hematocrit points per unit packed red blood cells transfused
Time frame: Cesarean duration, within 4-6 hours of fetal delivery
Total dose oxytocin bolus during cesarean
Time frame: 7 minutes after fetal delivery, 5 minutes after initiating study drug infusion
Uterine tone assessment: Obstetricians at the study institution use the following validated scale to grade uterine tone for all cesarean deliveries. The obstetrician places their hand directly on the uterine fundus and scores the adequacy of contraction. The interrater characteristics of this scale have been published (Cole et al, 2021).
The scale ranges from 0-10. A score of 0 is the worst possible score and represents a flaccid, atonic uterus. A score of 10 is the best possible score and represents a firmly-contracted uterus.
Time frame: 12 minutes after fetal delivery, 10 minutes after initiating study drug infusion
Uterine tone assessment: Obstetricians at the study institution use the following validated scale to grade uterine tone for all cesarean deliveries. The obstetrician places their hand directly on the uterine fundus and scores the adequacy of contraction. The interrater characteristics of this scale have been published (Cole et al, PMID 33652161).
The scale ranges from 0-10. A score of 0 is the worst possible score and represents a flaccid, atonic uterus. A score of 10 is the best possible score and represents a firmly-contracted uterus.
Time frame: Operating room duration, usually 2 hours
Total crystalloid required during cesarean delivery in mL
Time frame: every 5 minutes for 30 minutes after study drug infusion initiation, compared to baseline
Baseline mean arterial blood pressure recorded as average of first 6 mean arterial blood pressures recorded in operating room. Percent change calculated as measured mean arterial blood pressure minus baseline, divided by baseline. Reported here as the maximal decrease in mean arterial pressure. Repeated measures ANOVA reported in Statistical Analysis.
Time frame: every 5 minutes for 30 minutes after study drug infusion initiation, compared to baseline
Baseline heart rate recorded as average of first 6 heart rates recorded in operating room. Percent change calculated as measured heart rate minus baseline, divided by baseline. Maximal % increase in heart rate reported here. Repeated measures ANOVA used to analyze overall trend in Statistical Analysis below.
Time frame: Duration of operating room time, up to 240 minutes
Total phenylephrine in milligrams administered while in the operating room
Time frame: In the operating room prior to study drug administration (generally <30 minutes prior to fetal delivery and study drug administration)
Measured using an Abbott istat machine and CG8+ cartridge to determine venous blood gas ionized calcium levels
Time frame: At Tmax (conclusion of the 10-minute intravenous calcium chloride infusion
Generated from a 2-compartment population pharmacokinetic model in NONMEM using serial venous blood gas ionized calcium concentrations.
Time frame: Within 20 minutes of study drug administration
Data were not collected. This measure required blood specimens to be obtained at the time of tone scores and this was not done.
Time frame: Calculated at conclusion of operating room case
Pre-specified subgroup analysis of primary outcome:
Because the proposed mechanism of calcium action-improving uterine contractility-was not expected to improve bleeding from causes such as hysterotomy extension or arterial bleeding, the trial was powered for a prespecified subgroup analysis excluding patients with nonatonic blood loss documented in the surgeon's operative report. Documented nonatonic bleeding was defined as presence in the surgeon's operative report narrative of any of the following: hysterotomy extension, hysterotomy types other than low transverse (eg classical, T- or J-shaped), invasive or abnormally adherent placenta, placental abruption, uterine rupture, bleeding from leiomyomas, grade 3 or 4 vaginal lacerations, or cervical lacerations.
Stanford University
Other
Calcium Chloride for Prevention of Blood Loss From Uterine Atony During Intrapartum Cesarean Delivery (CALBLOC): a Double Blind, Randomized, Placebo Controlled Trial and Nested Population Pharmacokinetic and Pharmacodynamic Analysis
Acronym: CALBLOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06192836
Cesarean Section Complications, Dystocia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07688512
Dystocia, Elective Cesarean Section
View Trial DetailsNCT07606846
Cesarean Section, Dystocia
View Trial DetailsNCT03584854
Dystocia, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial Details